Further studies are needed to determine whether the improvements of reduced GH secretion by exogenous GH or GH releasing factors will have beneficial effects on hyperuricemia and other cardiometabolic risk in obesity children and adolescents. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.